MRVL vs TARS · P/E 100, rev $5.16B vs rev $336.0M
Marvell Technology Group Ltd (MRVL) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. TARS currently screens at market cap $2.66B.
Not investment advice. Open the MRVL and TARS stock pages for the full models.
Not investment advice.